EPO and anemia (phenotype): Since EPO acts primarily in the bone marrow to stimulate erythropoiesis and hemoglobin synthesis in several disorders, including anemias associated with chronic kidney failure, Zidovudine treatment of HIV and cancer chemotherapy, the original Epogen® and a number of other epoetin-alpha biosimilars have been used in the clinic [29,85,89].